iohexol has been researched along with Coronary Occlusion in 2 studies
Iohexol: An effective non-ionic, water-soluble contrast agent which is used in myelography, arthrography, nephroangiography, arteriography, and other radiographic procedures. Its low systemic toxicity is the combined result of low chemotoxicity and low osmolality.
iohexol : A benzenedicarboxamide compound having N-(2,3-dihydroxypropyl)carbamoyl groups at the 1- and 3-positions, iodo substituents at the 2-, 4- and 6-positions and an N-(2,3-dihydroxypropyl)acetamido group at the 5-position.
Coronary Occlusion: Complete blockage of blood flow through one of the CORONARY ARTERIES, usually from CORONARY ATHEROSCLEROSIS.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Wang, Y | 1 |
Zhao, HW | 1 |
Zhang, XJ | 1 |
Chen, BJ | 1 |
Yu, GN | 1 |
Hou, AJ | 1 |
Luan, B | 1 |
Liu, YH | 1 |
Liu, Y | 1 |
Tan, N | 1 |
Chen, JY | 1 |
Zhou, YL | 1 |
Luo, JF | 1 |
Yu, DQ | 1 |
Li, LW | 1 |
Li, HL | 1 |
Ye, P | 1 |
Ran, P | 1 |
2 other studies available for iohexol and Coronary Occlusion
Article | Year |
---|---|
CHA2DS2-VASC score as a preprocedural predictor of contrast-induced nephropathy among patients with chronic total occlusion undergoing percutaneous coronary intervention: a single-center experience.
Topics: Aged; Biomarkers; Blood Pressure; China; Chronic Disease; Contrast Media; Coronary Angiography; Coro | 2019 |
Contrast-induced nephropathy following chronic total occlusion percutaneous coronary intervention in patients with chronic kidney disease.
Topics: Acute Kidney Injury; Aged; Contrast Media; Coronary Occlusion; Female; Glomerular Filtration Rate; H | 2015 |